Midwest Chief Manufacturing Officer Resignation

Cannasouth Limited (NZX:CBD) Chief Manufacturing Officer Mark Balchin has resigned from his position effective 31 March 2023.

Mr Balchin was owner operator of Midwest Pharmaceutics NZ Ltd (Midwest), a contract manufacturing business, before Cannasouth purchased an initial 60% stake in Midwest in October 2019 and the remaining 40% shareholding in August 2021. At that time, he was appointed Chief Manufacturing Officer for the Cannasouth Group. After nearly 15 years leading Midwest, Mr Balchin is looking forward to focusing on new personal opportunities.

Cannasouth CEO Mark Lucas says, “During the next six-month period Mr Balchin will focus on scaling-up capacity at Midwest for our cornerstone customer. We are pleased Mark has given us a longer than normal notice period and for the support he has offered to transition to a new leader.

I would like to personally thank Mark for the contribution that he has made to the growth of Midwest and Cannasouth and wish him well for the future.“

-ENDS-

For further information visit www.cannasouth.co.nz or contact:

Mark Lucas
CEO / Executive Director
Email: [email protected]
Mobile: 021 484 649

Colin Foster
CFO / Company Secretary
Email: [email protected]
Mobile: 027 577 1498

---

Announcement PDF